Low sodium

Low sodium

PRESCRIBE BY BRAND AND FORMULATION

Also contains aluminium hydroxide,magnesium oxide & simeticone

Injection and tablets though tablets are poorly absorbed

Use 60mg capsules rather than 120mg

Second line to standard release tablets

Second line to standard release capsules

Unlicensed 

Note: All formulations currently have little to no availability due to ongoing regulatory investigations as described in DHSC Medicine Supply Notification, below. Which also gives advice about alternatives (see tables at end of document). The CCG acknowledges that it may be necessary to prescribe H2-receptor antagonists which are not in the formulary (when a PPI is not clinically appropriate) while ranitidine stock issues persist. Prescribers are advised to liaise with community pharmacies about stock availability of alternatives and to be mindful of comparative costs.

Check for interactions

Licensed liquid now available

Note : tablets are unlicensed

Misoprostol can prevent NSAID-associated ulcers. 

FOR PATIENTS WITH A HIGH OUTPUT STOMA, under the direction of a specialist, up to 40mg twice a day may be prescribed (off label use). See HWCCG Guidelines for Prescribing Stoma Appliances and Accessories in General Practice.

For patients with swallowing difficulties

For patients with swallowing difficulties and where lansoprazole orodispersible is not appropriate/ tolerated.

Tablets

For use in palliative care only.

FOR PATIENTS WITH A HIGH OUTPUT STOMA, under the direction of a specialist, doses up to 8mg four times a day may be required (off-label use). See HWCCG Guidelines for Prescribing Stoma Appliances and Accessories in General Practice.

For initiation by Gastroenterology Specialist only. 

• Colazide®

PRESCRIBE BY BRAND.

• Salofalk®

PRESCRIBE BY BRAND

• Pentasa®

PRESCRIBE BY BRAND

• Salofalk® (currently referred brand)


• Pentasa®

PRESCRIBE BY BRAND.

• Octasa® (currently the preferred brand)


• Asacol^® 


• Pentasa®


• Mezavant®- Once daily preparation.

PRESCRIBE BY BRAND

• Salofalk®

Plain tablets (1mg, 2.5mg, 5mg, 10mg, 20mg, 25mg), soluble tablets (5mg) and (5mg/5ml) oral solution unit dose vials are formulary approved. However 25mg tablets and 5mg soluble tablets are less cost effective options in primary care so alternatives should be prescribed if possible. Enteric-coated are no longer approved following an APC decision in February 2010.

Predsol®

Predsol®

PRESCRIBE BY BRAND

• Budenofalk® 

• Entocort CR®

PRESCRIBE BY BRAND

Budenofalk®

PRESCRIBE BY BRAND

Cortiment®

Budenofalk®

Colifoam®

PRESCRIBE BY BRAND

Only 2.5mg tablets should be prescribed and dispensed to avoid potentially fatal errors.

In Line With NICE TA187 and TA329

Possible treatment for adults with moderate to severe ulcerative colitis if conventional therapy hasn’t worked or isn’t suitable as per NICE TA329. (See Guidance for further details)

Possible treatment for Crohn's disease as per NICE TA187.
(See Guidance for further details)

In Line With NICE TA163, TA329 and TA187 (Replaces TA40)
For use in Crohns and Ulcerative Colitis as per NICE guidance

Inflectra is the biosimilar preparation of choice in gastroenterology

In line with NICE TA342 and TA352
Approved for the use of vedolizumab for both Crohn’s and ulcerative colitis.
(See guidance for further details)

Commissioned by NHS England when used for IBD in Children

In Line With NICE TA211

Tablets and syrup

Tablets and suppositories

Capsules and solution.

Used in paediatrics

Only for constipation in terminally ill patients of all ages - see BNF.

Only for constipation in terminally ill patients of all ages - see BNF.

•  Fleet Ready to use Enema®

For treating opioid-induced constipation- use in line with NICE TA651.

In line with NICE TA345

Only licensed GTN rectal ointment available in the UK

To be used as second line choice only in patients intolerant of or unresponsive to GTN ointment.

In line with NICE TA443

Commissioned by NHSE

• Creon® 10000


• Creon® 25000


• Creon® 40000


• Creon® Micro


• Nutrizym® 22


• Pancrex® V